Conformational bias in SARS-CoV-2 Spike CD4+ T-cell epitope dominance - Top-Institutions - MDSpire

Conformational Influence on Dominance of CD4+ T-cell Epitopes in SARS-CoV-2 Spike Protein

  • By

  • Samuel J. Landry

  • N. Kalaya Steede

  • Yali Tiomkin

  • Haley Smith

  • Ramgopal R. Mettu

  • Loren Gragert

  • Judith H. Aberle

  • Kevin J. Zwezdaryk

  • Crystal Zheng

  • Jay K. Kolls

  • Bronwyn M. Gunn

  • Amelie E. Murrell

  • Ivy V. Trinh

  • John S. Schieffelin

  • James E. Robinson

  • Elizabeth B. Norton

  • July 20, 2026

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    La Jolla Institute for Immunology
    La Jolla Institute for Immunology

    La Jolla, California

    Key Differentiators

    • Immunology

  • #2

    Ragon Institute of Mass General Brigham, MIT & Harvard
    Ragon Institute of Mass General Brigham, MIT & Harvard

    Boston, Massachusetts

    Key Differentiators

    • Immunology

  • #3

    University of Regensburg
    University of Regensburg

    Regensburg, Bavaria

    Key Differentiators

    • Immunology

  • #4

    University of Washington
    University of Washington

    Seattle, Washington

    Key Differentiators

    • Immunology

  • #5

    University Hospital Regensburg
    University Hospital Regensburg

    Regensburg, Bavaria

    Key Differentiators

    • Immunology

Original Source(s)

Conformational bias in SARS-CoV-2 Spike CD4+ T-cell epitope dominance

  • by Samuel J. Landry, N. Kalaya Steede, Yali Tiomkin, Haley Smith, Ramgopal R. Mettu, Loren Gragert, Judith H. Aberle, Kevin J. Zwezdaryk, Crystal Zheng, Jay K. Kolls, Bronwyn M. Gunn, Amelie E. Murrell, Ivy V. Trinh, John S. Schieffelin, James E. Robinson, Elizabeth B. Norton

  • July 20, 2026

Related Content

Integrated transcriptomic and immune analysis reveals distinct mitochondrial and immune signature in COVID-19 ARDS requiring invasive mechanical ventilation

Error in Figure

  • June 18, 2026

Updated COVID Shot Linked to Added Protection

Updated 2025-2026 vaccination was linked to added protection in a CDC-funded analysis that became part of a broader debate over routine vaccine monitoring.